Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 3 | GC3N4 | IM / LA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 3 | X1C891M | IM / LA |
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | 3 | 3CA30C1 | IM / RA |
During a record audit done by (withheld name), it was noted that Tdap and Polio were given on 3/5/25 before the recommended date. Last doses were given on 10/3/24 which made the interval too short and the doses were invalid. Catch-up schedule states there must be 6 months between doses.
None
None
None
NKDA
N/A